Published on Novartis Ireland HCP Portal (https://prod.hcp.novartis.ie)

Home > Printer-friendly > Safety profile

Safety Profile [1]

Safety profile [2]

ENTRESTO is indicated in adult patients for the treatment of symptomatic chronic heart failure with reduced ejection fraction.1,2

For full safety information, please refer to the Summary of Product Characteristics.1

On this page you can find information on specific adverse events.

Rate this content: 
No votes yet
Source URL:https://prod.hcp.novartis.ie/medicines/cardiology/entresto/safety-profile

Links
[1] https://prod.hcp.novartis.ie/medicines/cardiology/entresto/safety-profile [2] https://prod.hcp.novartis.ie/medicines/cardio-metabolic/entresto/safety